Resolution of all homozigous and heterozygous patients. Find out about the new. COMPLETE COVERAGE OF 30 GENES BY NEXT-GENERATION SEQUENCING. Measurement of the repertoire of B and T cell receptors by NGS. Looking for a laboratory training in NGS-Based HLA Typing? Expand your knowledge in the HLA typing by SBT and NGS.

Are planning a joint meeting September 28th-30th, 2018, at the Marriott River Center. Come and network with others in the field of cytometry and join us for the infamous GLIIFCA banquet.

Pharmaceutical, BioPharma, and Biotech. CRO, CMO, Clinical Research Centers. Meets FDA and EPA requirements. Explore the benefits and competitive edge that IST services provide to you! ISO 9001 and ISO 13485 certifications.

Melanoma Bridge 2012 Report is NOW published on JTM. Thank you for your precious participation into Immunotherapy and Melanoma Bridge 2017. Your very high scientific contribution and your invaluable enthusiasm made the meetings great! Please save the date for next appointment November 28 th.

16-18 November 2016 Munich, Germany. Focuses exclusively on how to deliver maximum clinical benefit through immune checkpoint monotherapy and combinations. Incorporating insights from Bristol-Myers Squibb. Attend this Immune Checkpoint Inhibitor event and fast track your immune-checkpoint development.

Returning for the third year, ICI Boston 2017. Is the only conference that focuses exclusively on delivering maximum clinical benefit through immune checkpoint monotherapy and combinations. Merck, BMS, Genentech, MedImmune, Novartis. And transform the success of your immuno-oncology approach.